Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jian Guo, Wenjie Tian, Huiping Lin, Liang Hu, Xuejuan Gao, Jiang Xia, Hao Yu, Hui Chen, Wei Li & Wenjuan Wu. (2024) Analytical and clinical validation of multiplex droplet digital PCR assay for detecting pathogenic fungal infection in lungs. Mycology 15:1, pages 110-119.
Read now
Read now
Armaghan-e-Rehman Mansoor, Jesse Thompson & Arif R. Sarwari. (2021) Delays in lumbar puncture are independently associated with mortality in cryptococcal meningitis: a nationwide study. Infectious Diseases 53:5, pages 361-369.
Read now
Read now
Vladimira Vuletic, Branimir Nevajda, Martina Spero & Darko Chudy. (2013) Difficulties with diagnosis and consequential poor outcome due to stigma of acquired immunodeficiency syndrome – a case report. Pathogens and Global Health 107:6, pages 325-328.
Read now
Read now
Articles from other publishers (46)
Rafael Calero-Bernal, Solange María Gennari, Santiago Cano, Martha Ynés Salas-Fajardo, Arantxa Ríos, Gema Álvarez-García & Luis Miguel Ortega-Mora. (2023) Anti-Toxoplasma gondii Antibodies in European Residents: A Systematic Review and Meta-Analysis of Studies Published between 2000 and 2020. Pathogens 12:12, pages 1430.
Crossref
Crossref
John Rubaihayo, Nazarius Mbona Tumwesigye & Josephine Birungi. 2023. Future Opportunities and Tools for Emerging Challenges for HIV/AIDS Control. Future Opportunities and Tools for Emerging Challenges for HIV/AIDS Control.
Adam Jönsson, Oskar Ljungquist & Karl Sörelius. (2022)
HIV
‐associated infective native aortic aneurysms
. APMIS 131:1, pages 3-12.
Crossref
Crossref
Laura Macca, Vittoria Moscatt, Manuela Ceccarelli, Ylenia Ingrasciotta, Giuseppe Nunnari & Claudio Guarneri. (2022) Hidradenitis Suppurativa in Patients with HIV: A Scoping Review. Biomedicines 10:11, pages 2761.
Crossref
Crossref
Alexandre Noël de Tilly & Sujeenthar Tharmalingam. (2022) Review of Treatments for Oropharyngeal Fungal Infections in HIV/AIDS Patients. Microbiology Research 13:2, pages 219-234.
Crossref
Crossref
Gordana HalecTim WaterboerNicole BrennerJulia ButtW. David HardyGypsyamber D'SouzaSteven WolinskyBernard J. MacatangayMichael PawlitaRoger Detels, Otoniel Martínez-MazaShehnaz K. Hussain. (2019) Serological Assessment of 18 Pathogens and Risk of AIDS-Associated Non-Hodgkin Lymphoma. JAIDS Journal of Acquired Immune Deficiency Syndromes 80:3, pages e53-e63.
Crossref
Crossref
E Sezgin, ML Van Natta, JE Thorne, MA Puhan & DA Jabs. (2018) Secular trends in opportunistic infections, cancers and mortality in patients with AIDS during the era of modern combination antiretroviral therapy. HIV Medicine 19:6, pages 411-419.
Crossref
Crossref
E. M. Aliouat, E. Dei-Cas, N. Gantois, M. Pottier, C. Pinçon, S. Hawser, A. Lier & D. B. Huang. (2018) In vitro and in vivo activity of iclaprim, a diaminopyrimidine compound and potential therapeutic alternative against Pneumocystis pneumonia. European Journal of Clinical Microbiology & Infectious Diseases 37:3, pages 409-415.
Crossref
Crossref
Lauren F. Collins, Meredith E. Clement & Jason E. Stout. (2017) Incidence, Long-Term Outcomes, and Healthcare Utilization of Patients With Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome and Disseminated Mycobacterium avium Complex From 1992–2015. Open Forum Infectious Diseases 4:3.
Crossref
Crossref
John Rubaihayo, Nazarius M. Tumwesigye, Joseph Konde-Lule, Henry Wamani, Edith Nakku-Joloba & Fredrick Makumbi. (2016) Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda. BMC Research Notes 9:1.
Crossref
Crossref
John Rubaihayo, Nazarius M. Tumwesigye, Joseph Konde-Lule & Fredrick Makumbi. (2016) Forecast analysis of any opportunistic infection among HIV positive individuals on antiretroviral therapy in Uganda. BMC Public Health 16:1.
Crossref
Crossref
Kristin M. Burkholder & Mary X. D. O’Riordan. 2016. The Rasputin Effect: When Commensals and Symbionts Become Parasitic. The Rasputin Effect: When Commensals and Symbionts Become Parasitic
301
357
.
Kpandja Djawe, Kate Buchacz, Ling Hsu, Miao-Jung Chen, Richard M. Selik, Charles Rose, Tiffany Williams, John T. Brooks & Sandra Schwarcz. (2015) Mortality Risk After AIDS-Defining Opportunistic Illness Among HIV-Infected Persons—San Francisco, 1981–2012. Journal of Infectious Diseases 212:9, pages 1366-1375.
Crossref
Crossref
Karen H. Keddy, Arvinda Sooka, Alfred Musekiwa, Anthony M. Smith, Husna Ismail, Nomsa P. Tau, Penny Crowther-Gibson, Frederick J. Angulo & Keith P. Klugman. (2015)
Clinical and Microbiological Features of
Salmonella
Meningitis in a South African Population, 2003–2013
. Clinical Infectious Diseases 61:suppl 4, pages S272-S282.
Crossref
Crossref
Satoshi Shibata, Takeshi Nishijima, Takahiro Aoki, Yoshinari Tanabe, Katsuji Teruya, Yoshimi Kikuchi, Toshiaki Kikuchi, Shinichi Oka & Hiroyuki Gatanaga. (2015) A 21-Day of Adjunctive Corticosteroid Use May Not Be Necessary for HIV-1-Infected Pneumocystis Pneumonia with Moderate and Severe Disease. PLOS ONE 10:9, pages e0138926.
Crossref
Crossref
Annie Standaert-Vitse, Cécile-Marie Aliouat-Denis, Anna Martinez, Sara Khalife, Muriel Pottier, Nausicaa Gantois, Eduardo Dei-Cas & El Moukhtar Aliouat. (2015) SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs. PLOS ONE 10:6, pages e0130358.
Crossref
Crossref
Cristina López-Sánchez, Vicenç Falcó, Joaquin Burgos, Jordi Navarro, María Teresa Martín, Adrià Curran, Lucía Miguel, Inma Ocaña, Esteve Ribera, Manel Crespo & Benito Almirante. (2015) Epidemiology and Long-Term Survival in HIV-Infected Patients With Pneumocystis jirovecii Pneumonia in the HAART Era. Medicine 94:12, pages e681.
Crossref
Crossref
Matthew J. Newman, Peggy S. Kraus, Kenneth M. Shermock, Brandyn D. Lau, Elliott R. Haut, Deborah B. Hobson & Michael B. Streiff. (2014) Nonadministration of thromboprophylaxis in hospitalized patients with HIV: A missed opportunity for prevention?. Journal of Hospital Medicine 9:4, pages 215-220.
Crossref
Crossref
T. N. Kakuda, B. Woodfall, T. De Marez, M. Peeters, K. Vandermeulen, F. Aharchi & R. M. W. Hoetelmans. (2013) Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers: results from two Phase 1 studies. Journal of Antimicrobial Chemotherapy 69:3, pages 728-734.
Crossref
Crossref
Mike Sathekge, Alex Maes & Christophe Van de Wiele. (2013) FDG-PET Imaging in HIV Infection and Tuberculosis. Seminars in Nuclear Medicine 43:5, pages 349-366.
Crossref
Crossref
Vasilios Pyrgos, Amy E. Seitz, Claudia A. Steiner, D. Rebecca Prevots & Peter R. Williamson. (2013) Epidemiology of Cryptococcal Meningitis in the US: 1997–2009. PLoS ONE 8:2, pages e56269.
Crossref
Crossref
Andreas Schapowal. (2012) Efficacy and safety of Echinaforce® in respiratory tract infectionsWirksamkeit und Sicherheit von Echinaforce® bei Atemwegsinfekten. Wiener Medizinische Wochenschrift 163:3-4, pages 102-105.
Crossref
Crossref
Chen Seong Wong, Francis A Lo, Philippe Cavailler, Oon Tek Ng, Cheng Chuan Lee, Yee Sin Leo & Arlene C Chua. (2012) Causes of Death in Hospitalised Human Immunodeficiency Virus (HIV)-infected Patients at a National Referral Centre in Singapore: A Retrospective Review from 2008 to 2010. Annals of the Academy of Medicine, Singapore 41:12, pages 571-576.
Crossref
Crossref
Rashed Noor, Shekhar Ranjan Saha, Farjana Rahman, Saurab Kishore Munshi, Md. Aftab Uddin & M. Majibur Rahman. (2012) Frequency of opportunistic and other intestinal parasitic infections in patients infected with human immunodeficiency virus in Bangladesh. Tzu Chi Medical Journal 24:4, pages 191-195.
Crossref
Crossref
Arlindo Schiesari Jr.Kátia Jaira Galisteu, Luciana Ventura Cardoso, Vanessa Maria Brogio Schiesari, Adriana Antônia da Cruz Furini, Andrea Regina Baptista Rossit & Ricardo Luiz Dantas Machado. (2012) Epidemiological Patterns of AIDS in a Reference Center from Catanduva, São Paulo State, Brazil. Open Journal of Medical Microbiology 02:03, pages 47-53.
Crossref
Crossref
Pablo A. Moncada & Jose G. Montoya. 2012. Sande's HIV/AIDS Medicine. Sande's HIV/AIDS Medicine
397
410
.
R. Mulder, Y.I.G.V. Tichelaar, H.G. Sprenger, A.B. Mulder & W.M. Lijfering. (2011) Relationship between cytomegalovirus infection and procoagulant changes in human immunodeficiency virus‐infected patients. Clinical Microbiology and Infection 17:5, pages 747-749.
Crossref
Crossref
Kate Buchacz, Rose K Baker, Frank J Palella, Joan S Chmiel, Kenneth A Lichtenstein, Richard M Novak, Kathleen C Wood & John T Brooks. (2010) AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study. AIDS 24:10, pages 1549-1559.
Crossref
Crossref
Emilie Catherinot, Fanny Lanternier, Marie-Elisabeth Bougnoux, Marc Lecuit, Louis-Jean Couderc & Olivier Lortholary. (2010) Pneumocystis jirovecii Pneumonia. Infectious Disease Clinics of North America 24:1, pages 107-138.
Crossref
Crossref
Mohammad A. ChaudharySantiago MorenoRitesh N. KumarGonzalo NoceaElamin Elbasha. (2009) Cost-Effectiveness Analysis of Raltegravir in Treatment-Experienced HIV Type 1-Infected Patients in Spain. AIDS Research and Human Retroviruses 25:7, pages 679-689.
Crossref
Crossref
Eva Sickinger, Hans-Bertram Braun, Gerald Praast, Myriam Stieler, Cordelia Gundlach, Claudia Birkenbach, John Prostko, Mary Ann Palafox, Edwin Frias, Stephen Hsu, Matthew Matias, Dominick Pucci, Michael Hausmann, Ulrich Sagel & Darwin Smith. (2009) Evaluation of the Abbott ARCHITECT Toxo IgM assay. Diagnostic Microbiology and Infectious Disease 64:3, pages 275-282.
Crossref
Crossref
Elżbieta Jabłonowska & Ewa Małolepsza. (2009) Causes of death in HIV-infected patients in the region of Lodz, Poland from 1995 through 2005. Open Medicine 4:2, pages 179-183.
Crossref
Crossref
Hoda Zeinab M. Amer, Joann Habermann, Leroy R. Sharer & Debra S. Heller. (2009) Acute Disseminated Toxoplasmosis in Patients With Human Immunodeficiency Virus Infection: A Clinical Challenge. Infectious Diseases in Clinical Practice 17:3, pages 201-205.
Crossref
Crossref
M B J Beadsworth, D Cohen, L Ratcliffe, N Jenkins, W Taylor, F Campbell, N J Beeching & B Azadeh. (2009) Autopsies in HIV: still identifying missed diagnoses. International Journal of STD & AIDS 20:2, pages 84-86.
Crossref
Crossref
Matthew C. Uhlenkott, David M. Aboulafia, Susan E. Buskin, Erin M. Kahle & Elizabeth Barash. (2008) Causes of Death in the Era of Highly Active Antiretroviral Therapy: A Retrospective Analysis of a Hybrid Hematology-Oncology and HIV Practice and the Seattle/King County Adult/Adolescent Spectrum of HIV-Related Diseases Project. The American Journal of the Medical Sciences 336:3, pages 217-223.
Crossref
Crossref
. (2008) Inferior Clinical Outcome of the CD4+ Cell Count–Guided Antiretroviral Treatment Interruption Strategy in the SMART Study: Role of CD4+ Cell Counts and HIV RNA Levels during Follow-up. The Journal of Infectious Diseases 197:8, pages 1145-1155.
Crossref
Crossref
David B. HannaMelissa R. PfeifferLucia V. TorianJudith E. Sackoff. (2008) Concurrent HIV/AIDS Diagnosis Increases the Risk of Short-Term HIV-Related Death among Persons Newly Diagnosed with AIDS, 2002–2005. AIDS Patient Care and STDs 22:1, pages 17-28.
Crossref
Crossref
Christian Jost, Ingrid Reiter-Owona & Oliver Liesenfeld. (2007) The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8−/− mice. Parasitology Research 101:6, pages 1603-1609.
Crossref
Crossref
Patrick Peretti-Watel, Bruno Spire, Yolande Obadia & Jean-Paul Moatti. (2007) Discrimination against HIV-Infected People and the Spread of HIV: Some Evidence from France. PLoS ONE 2:5, pages e411.
Crossref
Crossref
C. Hoffmann, M. Ernst, P. Meyer, E. Wolf, T. Rosenkranz, A. Plettenberg, A. Stoehr, H.-A. Horst, K. Marienfeld & C. Lange. (2007) Evolving characteristics of toxoplasmosis in patients infected with human immunodeficiency virus-1: clinical course and Toxoplasma gondii-specific immune responses. Clinical Microbiology and Infection 13:5, pages 510-515.
Crossref
Crossref
Alexandra Ducancelle, Sophie Alain, Françoise Petit, Marie-José Sanson Le Pors & Marie-Christine Mazeron. (2007) Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet. Journal of Virological Methods 141:2, pages 212-215.
Crossref
Crossref
Carlos José Dornas Gonçalves Barbosa, Rodrigo Juliano Molina, Murilo Barcelos de Souza, Ana Cristina A. Silva, Adilha Rua Micheletti, Marlene Antonia dos Reis, Vicente de Paula Antunes Teixeira & Mario León Silva-Vergara. (2007) Disseminated toxoplasmosis presenting as sepsis in two AIDS patients. Revista do Instituto de Medicina Tropical de São Paulo 49:2, pages 113-116.
Crossref
Crossref
Masayuki Murata, Norihiro Furusyo, Shigeru Otaguro, Iwao Ariyama, Jun Hayashi, Norihiro Furusyo, Jun Hayashi & Shigeki Nabeshima. (2007) HIV infection with concomitant cerebral toxoplasmosis and disseminated histoplasmosis in a 45-year-old man. Journal of Infection and Chemotherapy 13:1, pages 51-55.
Crossref
Crossref
Alok KumarKrishna R. Kilaru, Sheila Forde & Timothy C. Roach. (2016) Changing HIV Infection–Related Mortality Rate and Causes of Death Among Persons With HIV Infection Before and After the Introduction of Highly Active Antiretroviral Therapy. Journal of the International Association of Physicians in AIDS Care 5:3, pages 109-114.
Crossref
Crossref
S. Solaymani-Mohammadi & W.A. PetriJr.Jr.. (2006) Zoonotic implications of the swine-transmitted protozoal infections. Veterinary Parasitology 140:3-4, pages 189-203.
Crossref
Crossref
Alain Saraux, Sandrine Jousse, Anne Roudaut & Valérie Devauchelle. (2006) Particularités des infections ostéoarticulaires chez les patients VIH positifs et les toxicomanes. Revue du Rhumatisme 73:2, pages 163-167.
Crossref
Crossref